Acurx Pharmaceuticals LLC (ACXP) — Financial Flexibility Index
Latest as of March 2026:
-0.56x
Acurx Pharmaceuticals LLC (ACXP) has a Financial Flexibility Index of -0.56x as of March 2026. Free cash flow of $-1.41 Billion (operating CF $-1.41 Billion minus capex $0.00) represents -1% of total liabilities ($2.53 Billion).
Financial Flexibility Index
-0.56x
Free Cash Flow / Total Liabilities
Free Cash Flow
$-1.41 Billion
Operating CF − Capex
Total Liabilities
$2.53 Billion
USD
Capital Expenditures
$0.00
USD
Acurx Pharmaceuticals LLC Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Acurx Pharmaceuticals LLC across 7 annual periods. See Acurx Pharmaceuticals LLC working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Acurx Pharmaceuticals LLC (2019–2025)
Year-by-year free cash flow to debt coverage for Acurx Pharmaceuticals LLC. For the full company profile including market capitalisation, see ACXP market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2803.78x | $-6.79 Billion | $-6.79 Billion | $2.42 Million | ▼ -87464.5% |
| 2024 | -3.20x | $-10.38 Million | $-10.38 Million | $3.24 Million | ▲ +0.6% |
| 2023 | -3.22x | $-9.80 Million | $-9.80 Million | $3.04 Million | ▲ +11.9% |
| 2022 | -3.66x | $-7.54 Million | $-7.54 Million | $2.06 Million | ▲ +38.4% |
| 2021 | -5.94x | $-5.01 Million | $-5.01 Million | $843.91K | ▲ +7.4% |
| 2020 | -6.42x | $-3.35 Million | $-3.35 Million | $522.43K | ▼ -175.5% |
| 2019 | -2.33x | $-3.99 Million | $-3.99 Million | $1.71 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities